Embracing Future Holdings Ltd (SGX:8YY) Share Price

Company Profile

Business description
Embracing Future Holdings Ltd formerly, Biolidics Ltd is engaged in technology development, technology transfer, marketing, sales, and distribution of biomedical technology, life, and medicine science-related products and services, and investment holding. The company's business segments are: Cancer, Infectious Diseases, E-sports, and Corporate. The company generates the majority of its revenue from the E-sports segment, which involves identifying and assessing potential collaboration partners, technology, digital platforms, products, and services related to E-Sports.. Its operations are spread across Singapore, Japan, China, Europe, the United States, Hong Kong, the Philippines, Indonesia, and other countries.
Contact
18 Howard Road
No. 11-09 Novelty BizCentre
Singapore369585
SGP
T: +65 64820668
https://www.biolidics.com
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
7

Recommended

We think Microsoft stock is moderately undervalued.

Dan Romanoff, CPA | 30 October 2025

Q3 earnings reflected sequential improvement driven by record auto deliveries and energy storage deployments.

Seth Goldstein, CFA | 30 October 2025

Well priced Aussie shares that offer a tax rebate.

Shani Jayamanne | 29 October 2025

Index	Last price	Change	% Change
All Ordinaries	9,178.00	28.70	-0.31%
CAC 40	8,157.29	43.59	-0.53%
DAX 40	24,118.89	5.32	-0.02%
Dow JONES (US)	47,522.12	109.88	-0.23%
FTSE 100	9,760.06	3.92	0.04%
HKSE	25,999.70	282.99	-1.08%
NASDAQ	23,581.14	377.33	-1.57%
Nikkei 225	52,244.44	918.83	1.79%
NZX 50 Index	13,548.32	89.03	0.66%
S&P 500	6,822.34	68.25	-0.99%
S&P/ASX 200	8,881.90	31.30	-0.35%
SSE Composite Index	3,955.92	30.98	-0.78%